Re-appointment of Mr. Dhananjaya Alli (DIN: 00610909) as an Whole Time Director of company
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Vista Pharmaceuticals has re-appointed Mr. Dhananjaya Alli (DIN: 00610909) as a Whole Time Director for a second term of 3 years, effective from 19 October 2025 to 18 October 2028, subject to shareholder approval. Mr. Dhananjaya Alli is a Promoter Director of the company, holds a Ph.D. and M.S. in Pharmaceutical Sciences, and has been instrumental in setting up and growing the business. He currently holds 28,87,424 equity shares in the company. The re-appointment was approved by the Board based on the recommendation of the Nomination and Remuneration Committee at a meeting held on 13 August 2025.
This is a routine re-appointment of an existing promoter director, providing continuity in leadership. The move is generally neutral for shareholders, though his large shareholding (28.87 lakh shares) signals promoter commitment to the company.